hemophilia antibody therapy (Genmab/Sanquin)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namehemophilia antibody therapy (Genmab/Sanquin)

Drug Alias Namehemophilia antibody therapy (Genmab)anti-Factor VIII antibody-specific antibodies (Genmab/Sanquin)hemophilia antibody therapy (Sanquin)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionCoagulation factor VIII stimulants

TargetsCoagulation factor VIII

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSanquin Blood Supply Foundation

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGenmab A/S Sanquin Blood Supply Foundation

Active IndicationsN/A

Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A